EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Machine Learning in Drug Development for Neurological Diseases: A Review of Blood Brain Barrier Permeability Prediction Models

Aryon Eckleel Nabi, Pedram Pouladvand, Litian Liu, Ning Hua, Cyrus Ayubcha iD

Molecular Informatics · 2025-03 · 44 (3)

DOI: 10.1002/minf.202400325 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Informatics, online erschienen am 27.03.2025. Verfasst von Aryon Eckleel Nabi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Machine Learning, Drug Development, Nervous System Diseases. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The blood brain barrier (BBB) is an endothelial‐derived structure which restricts the movement of certain molecules between the general somatic circulatory system to the central nervous system (CNS). While the BBB maintains homeostasis by regulating the molecular environment induced by cerebrovascular perfusion, it also presents significant challenges in developing therapeutics intended to act on CNS targets. Many drug development practices rely partly on extensive cell and animal models to predict, to an extent, whether prospective therapeutic molecules can cross the BBB. In interest to reduce costs and improve prediction accuracy, many propose using advanced computational modeling of BBB permeability profiles leveraging empirical data. Given the scale of growth in machine learning and deep learning, we review the most recent machine learning approaches in predicting BBB permeability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierMachine LearningDrug DevelopmentNervous System DiseasesHumansAnimalsPermeability

Stichwörter der Autor:innen

artificial neural network (ANN)blood brain barrier (BBB)central nervous system (CNS)deep learning (DL)deep neural network (DNN)extra-tree (EXT)extreme gradient boosting (XGBoost)fingerprints (FPs)in silico modelmachine learning (ML)molecular descriptor(s) (MDs)quantitative structure-activity relationship (QSAR) modelrandom forest (RF)recurrent neural network (RNN)simplified molecular line entry system (SMILES)

Autor:innen und Institutionen

  • Harvard Medical School, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Department of Epidemiology, Harvard Chan School of Public Health, Boston, MA, USA.
  • Boonshoft School of Medicine, Wright State University, Dayton, OH, USA.
  • Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Boston, MA, USA.

ORCID-Profile: Cyrus Ayubcha

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Nabi, A. E., Pouladvand, P., Liu, L., Hua, N., & Ayubcha, C. (2025). Machine Learning in Drug Development for Neurological Diseases: A Review of Blood Brain Barrier Permeability Prediction Models. Molecular Informatics, 44(3). https://doi.org/10.1002/minf.202400325

Vancouver

Nabi AE, Pouladvand P, Liu L, Hua N, Ayubcha C. Machine Learning in Drug Development for Neurological Diseases: A Review of Blood Brain Barrier Permeability Prediction Models. Molecular Informatics. 2025;44(3). doi:10.1002/minf.202400325

BibTeX
@article{Nabi2025,
  author = {Nabi, Aryon Eckleel and Pouladvand, Pedram and Liu, Litian and Hua, Ning and Ayubcha, Cyrus},
  title = {Machine Learning in Drug Development for Neurological Diseases: A Review of Blood Brain Barrier Permeability Prediction Models},
  journal = {Molecular Informatics},
  year = {2025},
  volume = {44},
  number = {3},
  doi = {10.1002/minf.202400325}
}
Kostenlos starten →